$IPSC 8-K SEC Filings

Filed On	Filing
02 Oct 2026	8-K: Regulation FD Disclosure; Other Events CNTY - 813: Scalable Production of Allo - Evasion TM 5.0 - Engineered iPSC Islets for Off - the - Shelf Cell Therapies G. Grant Welstead, PhD SVP, Head of Research
09 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure PHILADELPHIA, September 9, 2026 - Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1...
12 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
16 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
08 Jun 2026	8-K: Other Events
13 May 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	8-K: Other Events
12 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Jan 2026	8-K: Submission of Matters to a Vote of Security Holders; Other Events
12 Jan 2026	8-K: Regulation FD Disclosure
08 Jan 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
29 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
12 Dec 2025	8-K: Regulation FD Disclosure
09 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
13 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
29 Aug 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
07 Jul 2025	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation
16 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders

Comments